Optimized polymerase chain reaction-based single-strand conformation polymorphism analysis of p53 gene applied to Bulgarian patients with invasive breast cancer

Clinical and Experimental Medicine

Volumn 3, Issue 3, 2003, Pages 173-180

  Krasteva, M E ^a   Garanina, Z ^b   Georgieva, E I ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

^b National Cancer Hospital   (Bulgaria)

Author keywords

Cancer; Mutation; p53; Polymerase chain reaction; Single strand conformation polymorphism

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BULGARIA; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL SIGNIFICANCE;

BASE SEQUENCE; BREAST NEOPLASMS; BULGARIA; CARCINOMA, DUCTAL; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, P53; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TEMPLATES, GENETIC;

EID: 0344514011     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-003-0022-z     Document Type: Article

References (53)

1. Nigro LM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Wetson A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse tumor types. Nature 342:705-708
2. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
3. Chang F, Syrjanen S, Kurvinen K, Syrjanen K (1993) The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 88:174-186
4. Chang F, Syrjanen S, Tervahauta A, Syrjanen K (1993) Tumorigenesis associated with the p53 tumor suppressor gene. Br J Cancer 68:653-661
5. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B (1994) Multifactorial analysis of p53 alterations in human cancers. Int J Cancer 57:1-9
6. Chang F, Syrganen S, Syrganen K (1995) Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 13:1009-1022
7. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D (1994) The role the of p53 tumor-suppressor gene in tumorigenesis. Br J Cancer 69:409-416
8. Pellegata NS, Ranzani GN (1996) The significance of p53 mutations in human cancers. Eur J Histochem 40:273-282
9. Boyle JO, Koch W, Hruban RH, van der Reit P, Sidransky D (1993) The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53:4477-4480
10. Rhyu M-G, Park W-S, Jung Y-J, Choi SW, Meltzer SJ (1994) Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology 106:1584-1588
11. Clahsen PC, van de Velde CJ, Duval C, Pallud C, Mandard AM, Deroide DA, van de Broek L, Sahmound TM, van de Vijver MJ (1998) p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer. J Clin Oncol 16:470-479
12. Koechli O, Schaer G, Seifert B, Hornung R, Haller U, Eppenber U, Muller H (1994) Mutant p53 protein associated with chemosensitivity in breast cancer specimens. Lancet 344:1647-1648
13. Formenti SC, Dunnington G, Uzieli B, Lenz H, Keren-Rosenberg S, Silberman H, Spicer D, Denk M, Leichman G, Groshen S, Watkins K, Muggia F, Florentine B, Press M, Danenberg K, Danenberg P (1997) Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion of 5-fluorouracil and radiation therapy. Int J Radiat Oncol Biol Phys 39:1059-1068
14. Chiarugi V, Magnelli L, Cinelli M ( 1998) Role of p53 mutations in the radiosensitivity status of tumor cells. Tumori 84:517-520
15. Roth JA, Cristiano RJ (1997) Gene therapy for cancer: what have we done and where are we going. J Nat Cancer Inst 89:21-39
16. Chang EH, Pirollo KF, Bouker KB (2000) Tp53 gene therapy: a key to modulating resistance to anticancer therapies. Mol Med Today 6:358-364
17. Nagamine CM, Chan K, Lau YFC ( 1989) A PCR artifact: generation of heteroduplexes. Am J Hum Genet 45:337-339
18. White MB, Carvalho M, Derse D, O'Brien SJ, Dean M (1992) Detecting single base substitutions as heteroduplex polymorphism. Genomics 12:301-306
19. Myers RM, Maniatis T, Lerman LS (1987) Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 155:501-527
20. Myers RM, Lumelski N, Lermantil L, Maniatis T (1985) Detection of single base substitution in total genomic DNA. Nature 313:495-498
21. Beck JS, Kwitek AE, Cogen PH, Metzger AK, Duyk GM, Sheffield VC (1993) A denaturing gradient gel electrophoresis assay for sensitive detection of p53 mutations. Hum Genet 91:25-30.
22. Myers RM, Larin Z, Maniatis T (1985) Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA-DNA duplexes. Science 230:1242-1246
23. Cotton RG, Rodrigues NR, Campbell RD (1988) Reactivity of cytosine and thymine in single-base pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc Natl Acad Sci U S A 85:4397-4401
24. Ganguly A, Prockop DJ ( 1990) Detection of single base mutations by reaction of DNA heteroduplexes with a water-soluble carbodiimide followed by primer extension: application to products from the polymerase chain reaction. Nucleic Acids Res 18:3933-3939
25. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proc Natl Acad Sci U S A 86:2766-2770
26. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879
27. Jap E, McGee J (1992) Nonisotopic SSCP detection in PCR products by ethidium bromide staining. Trends Genet 8:49
28. Ainsworth P, Surh L, Coulter-Mackie M (1991) Diagnostic single strand conformation polymorphism, (SSCP): a simplified non-radioisotopic method as applied to Tay-Sachs B1 variant. Nucleic Acid Res 19:405-406
29. Bosari S, Marchetti F, Buttitta F, Graziani D, Borsani G, Loda M, Bevilacqua G, Coggi G (1995) Detection of p53 mutations by single-strand conformation polymorphism (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver stained SSCP analysis. Diagn Mol Pathol 4:249-255
30. Tolbert DM, Noffsinger AE, Miller MA, DeVoe GW, Sttemmermann GN, Macdonald JS, Fenoglio-Preiser CM (1999) p53 immunoreactivity and single-strand conformation polymorphism analysis often fail to predict p53 mutational status. Mod Pathol 12:54-60
31. Maekawa M, Sudo K, Kanno T (1993) Search for improved electrophoretic conditions for PCR-single-strand conformation polymorphism analysis: is an SDS buffer condition useful? PCR Methods Appl 3:130-132
32. Savov A, Angelicheva D, Jordanova A, Eigel A, Kalaydjieva L (1992) High percentage acrylamide gels improve resolution in SSCP analysis. Nucleic Acid Res 20:6741-6742
33. O'Connell C, Tian J, Juhasz A, Wenz HM, Altha D (1998) Development of standard reference materials for diagnosis of p53 mutations: analysis by slab gel-SSCP. Electrophoresis 19:164-171
34. Atha D, Wenz HM, Morehead H, Tian J, O'Connell C (1998) Detection of p53 point mutations by single strand conformation polymorphism (SSCP): analysis by capillary electrophoresis. Electrophoresis 19:172-179
35. Hongyo T, Buzard G, Calvert R, Weghorst C (1993) "Cold" SSCP: a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analysis. Nucleic Acid Res 21:3637-3642
36. Glavac D, Dean M (1993) Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat 2:404-414
37. Bastos E, Cravador A, Azevedo J, Guedes-Pinto H (2001) Single strand conformation polymorphism (SSCP) detection in six genes in Portuguese indigenous sheep breed "Churra da Terra Quente". Biotechnol Agron Soc Environ 5:7-15
38. Ahmad NN, Cu-Un ieng AB, Donoso LA ( 1995) Modification of standard proteinase-K/phenol method for DNA isolation to improve yield and purity from frozen blood. J Med Genet 32:129-130
39. Deng G, Chen L-C, Schott DR, Thor A, Bhargava V, Ljung B-M, Chew K, Smith HS (1994) Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 54:499-505
40. Wallace RB, Miyada CG (1987) Oligonucleotide probes for the screening of recombinant DNA libraries. In: Berger SL, Kimmel AR (eds) Methods of enzymology: guide to molecular cloning techniques. Academic Press, San Diego, pp 432-442
41. Niederacher D, Schnurch HG, An HX, Ellenberg I, Dall P, van Roeyen CRC, Kuppers V, Beckmann MW (1996) Detection of sequential genetic alterations relevant for breast cancer development. Eur J Cancer Prev 5:497-503
42. Moll UM, Riou G, Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A 89:7269-7266
43. Elledge RM, Allred DC (1994) The p53 tumor suppressor gene in breast cancer. Breast Cancer Res Treat 32:39-47
44. Devilee P, Cornelisse CJ (1994) Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198:113-130
45. El-Ashry D, Lippman ME ( 1994) Molecular biology of breast carcinoma. World J Surg 18:12-20
46. Anelli A, Anelli TFM, Youngson B, Rosen PP, Borgen PI (1995) Mutations of the p53 gene in male breast cancer. Cancer 75:2233-2238
47. Hartmann A, Blaszyk H, McGovern RM, Schroeder JJ, Cunningham J, De Vries EMG, Kovach JS, Sommer SS (1995) p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene 10:681-688
48. Tanyi J, Tory K, Bankfalvi A, Shroder W, Rath W, Fuzesi L (1999) Analysis of p53 mutation and cyclin D1 expression in breast tumors. Pathol Oncol Res 2:90-94
49. Callahan R (1992) p53 mutations, another breast cancer prognostic factor. J Natl Cancer Inst 84:826-827
50. Thompson AM, Anderson TJ, Condie A, Prosser J, Chety U, Carter DC, Evans HJ, Steel CM (1992) p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer 50:528-532
51. Elledge RM, Allred DC (1998) Prognostic and predictive value of p53 and p21 in breast cancer. Breast Cancer Res Treat 52:79-98
52. Andre S, Pereira H, Nogueira M, Cardoso P, Bernardo M, Meneses e Sousa J, Soares J (1997) p53 overexpression is a prognostic indicator in poorly differentiated, node negative and T1/T2 invasive ductal breast cancer patients. Breast 6:194-201
53. Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S (1991) Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci U S A 88:10657-10661